Rampart Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,928
Closed -$957K 5
2020
Q3
$957K Sell
10,928
-24,887
-69% -$2.34M 0.6% 51
2020
Q2
$3.52M Buy
35,815
+13,593
+61% +$1.2M 0.59% 34
2020
Q1
$1.69M Buy
22,222
+5,016
+29% +$427K 0.8% 23
2019
Q4
$1.52M Buy
17,206
+428
+3% +$35.5K 0.19% 155
2019
Q3
$1.27M Sell
16,778
-278
-2% -$19.1K 0.16% 188
2019
Q2
$1.24M Sell
17,056
-1,230
-7% -$96.7K 0.15% 196
2019
Q1
$1.47M Buy
18,286
+2,090
+13% +$171K 0.17% 180
2018
Q4
$1.49M Sell
16,196
-5,634
-26% -$495K 0.41% 64
2018
Q3
$1.59M Sell
21,830
-1,639
-7% -$155K 0.7% 31
2018
Q2
$2.17M Sell
23,469
-19,186
-45% -$1.87M 0.21% 136
2018
Q1
$4.04M Buy
42,655
+23,104
+118% +$2.54M 0.39% 79
2017
Q4
$1.89M Sell
19,551
-2,227
-10% -$210K 0.73% 30
2017
Q3
$1.94M Buy
21,778
+1,255
+6% +$95.5K 0.65% 34
2017
Q2
$1.49M Buy
20,523
+16,019
+356% +$1.08M 0.54% 40
2017
Q1
$293K Buy
+4,504
New +$283K 0.1% 50

Other funds holding ABBV

Rampart Investment Management's ABBV Position: Q4 2020 in Review

Rampart Investment Management sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 10,928 shares — an estimated $957K sold.

Rampart Investment Management first reported a position in ABBV in Q1 2017 and held it in 15 quarters. The position peaked at $4.04M in Q1 2018. 2,598 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Rampart Investment Management reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 10,928 AbbVie shares in Q4 2020, an estimated $957K.
  • Rampart Investment Management first reported a position in AbbVie in Q1 2017 and held it in 15 quarters.
  • Rampart Investment Management's AbbVie position peaked at $4.04M in Q1 2018.
  • 2,598 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.